Table 3.
Resistance rates of the clinical isolates of Enterococcus faecalis to antimicrobial agents.
| Enterococcus faecalis | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Antibiotics | R% (n) | R% (n) | R% (n) | R% (n) | R% (n) |
| Ampicillin | 0.6 (161) | 1.7 (525) | 0.8 (594) | 4.2 (600) | 2.3 (575) |
| Ampicillin/sulbactam | 0 (162) | 0.3 (509) | 0.2 (569) | 0.9 (550) | 0.4 (540) |
| Gentamicin High Level | 61.1 (162) | 63.5 (509) | 54.9 (565) | 56.7 (522) | 60.3 (63) |
| Imipenem | 0 (163) | 1.5 (534) | 0.8 (595) | 3.3 (601) | 1.6 (576) |
| Levofloxacin | 34.9 (63) | 52.4 (166) | 46.3 (203) | 38.0 (192) | 29.5 (190) |
| Linezolid | 0 (175) | 0.4 (528) | 0.5 (598) | 1.5 (608) | 0.9 (581) |
| Nitrofurantoin | 0 (60) | 0.6 (166) | 0 (202) | 1 (191) | 0.5 (190) |
| Streptomycin High Level | 51.9 (162) | 52.8 (504) | 44.3 (566) | 45.1 (546) | 34.0 (529) |
| Teicoplanin | 1.1 (175) | 1.8 (542) | 0.8 (601) | 1.8 (609) | 1.7 (573) |
| Tigecycline | 0 (171) | 0.2 (523) | 0.2 (596) | 1.6 (608) | 1.7 (572) |
| Vancomycin | 0.6 (174) | 3.1 (541) | 1.3 (599) | 1.8 (606) | 1.9 (575) |